Publication | Closed Access

The CHORUS (Cerivastatin in Heart Outcomes in Renal Disease: Understanding Survival) protocol: A double-blind, placebo-controlled trial in patients with ESRD

HemodialysisUrologyHeart FailureRenal FunctionCardiovascular DiseaseKidney FailureChronic Kidney DiseaseUnderstanding SurvivalHeart OutcomesPlacebo-controlled TrialNephrologyAcute Kidney InjuryMedicineEnd-stage Renal Disease